{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Two New Applications for Trastuzumab (Herceptin®) Biosimilars Pending at FDA",
"url": "https://www.lexblog.com/2017/08/11/two-new-applications-trastuzumab-herceptin-biosimilars-pending-fda/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-3H3TRPKY",
"url": "https://www.lexblog.com/lib/3H3TRPKY/"
},
"datePublished": "2017-08-11T14:43:39-04:00",
"dateModified": "2021-11-10T06:58:41-05:00",
"author": {
"@type": "Person",
"name": "Nicole Gifford"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Food, Drug & Agriculture",
"sourceUrl": "http://www.biosimilarsip.com/?p=4039",
"sourceStability": "may-move"
}